RedHill Biopharma
Israel - Tel AvivPharmaceutical
Focus: RedHill Biopharma is an Israeli pharmaceutical company focused on orally-administered, small molecule drugs for inflammatory, gastrointestinal, and oncology indications. Founded in 2017, the company operates in specialized therapeutic areas with limited public visibility on scale and market position.
Profile data last refreshed Yesterday · AI intelligence enriched 1w ago
Open Jobs
0
About RedHill Biopharma
AI assessmentNot HiringNo open roles listed right now. Follow RedHill Biopharma to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthStrong
Pipeline
Late-stage
6 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
ABC294640
CholangiocarcinomaClinical Trials (1)
NCT03414489Expanded Access for the Treatment of Advanced Cholangiocarcinoma With ABC294640 (Yeliva ®)
N/AHelp build intelligence for RedHill Biopharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.